Emerging epidemic: Diabetes in older adults: Demography, economic impact, and pathophysiology

Diabetes Spectrum

Volumn 19, Issue 4, 2006, Pages 221-228

  Gambert, Steven R ^a,b   Pinkstaff, Sally ^a,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b SINAI HOSPITAL OF BALTIMORE   (United States)

^c Sinai Hospital   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

AGING; CLINICAL FEATURE; DEMOGRAPHY; DISEASE ASSOCIATION; EPIDEMIC; HEALTH CARE COST; HEALTH ECONOMICS; HUMAN; INSULIN DEFICIENCY; INSULIN DEPENDENT DIABETES MELLITUS; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOPHYSIOLOGY; PREVALENCE; QUALITY OF LIFE; REVIEW;

EID: 33845363138     PISSN: 10409165     EISSN: None     Source Type: Journal    
DOI: 10.2337/diaspect.19.4.221     Document Type: Review

References (54)

1. Narayan KM, Boyle JP, Thompson J: Lifetime risk for diabetes mellitus in the United States. JAMA 290:1884-1890, 2003
2. Mary SC, Fried LP, Volpato S, Williamson J, Brancati FL, Blaum CS: Patterns of disability related to diabetes mellitus in older women. J Gerontol A Biol Sci Med Sci 59:148-153, 2004
3. Blaum CS, Ofstedal MB, Lana KM, Wray LA: Functional status and health outcomes in older americans with diabetes mellitus. J Am Geriar Soc 51:745-753, 2003
4. Bureau of Census Report [article online]. Available from www.census.gov/prod/ 2006pubs/p23-209.pdf
5. DeFronzo RA: Pathogenesis of type 2 diabetes mellitus. Med Clin North Am 88:787-835,2004
6. Meneilly GS: Pathophysiology of diabetes in the elderly. In Diabetes in Old Age. 2nd ed. Sinclair AJ, Finucane P, Eds. Chichester, U.K., John Wiley & Sons, 2001, p. 155-164
7. Sturrock NDC, Page SR, Clarke P, Tattersall RB: Insulin dependent diabetes in nonagenarians. BMJ 310:1117-1118, 1995
8. Meneilly GS, Tildesley H, Elliott T, Palmer JP, Juneja R: Significance of GAD positivity in elderly patients with diabetes. Diabet Med 17:247-251, 2000
9. Chen M, Bergman RN, Pacini G, Porte D: Pathogenesis of age-related glucose intolerance in man: insulin resistance and decreased beta-cell function. J Clin Endocrinol Metab 60:13-20, 1985
10. Reaven GM, Reaven EP: Effects of age on various aspects of glucose and insulin metabolism. MoL Cell Biochem 31:37-47, 1980
11. Samos LF, Roos BA: Diabetes mellitus in older persons. Med Clin North Am 82:791-803, 1998
12. Hornick TR, Kowal J: Clinical epidemiology of endocrine disorders in the elderly. Endo Metab Clin North Am 26:145-163, 1997
13. American Diabetes Association: Diagnosis and classification of diabetes mellitus (Position Statement). Diabetes Care 29 (Suppl. 1):S43-S48, 2006
14. Kanaya AM, Harris T, Goodpaster BH, Tylavsky F, Cummings SR: Adipocytokines attenuate the association between visceral adiposity and diabetes in older adults. Diabetes Care 27:1375-1380, 2004
15. Gumbiner B, Polonsky KS, Beltz WF, Wallace P, Brechtel G, Fink RI: Effects of aging on insulin secretion. Diabetes 38:1549-1556, 1989
16. Roder ME, Schwartz RS, Prigeon RL, Kahn SE: Reduced pancreatic B cell compensation to the insulin resistance of aging: impact on proinsulin and insulin levels. J Clin Endocrinol Metab 85:2275-2280, 2000
17. Houmard JA, Weidner MD, Dolan PL: Skeletal muscle GLUT4 protein concentrationa and aging in humans. Diabetes 44:555-560, 1995
18. Shimokata H, Muller DC, Fleg JL, Sorkin J, Ziemba AW, Andres R: Age as independent determinant of glucose tolerance. Diabetes 40:44-51, 1991
19. Obisesan TO, Aliyu MH, Bond V, Adams RG, Akomolate A, Rotimi CN: Ethnic and age-related fat free mass loss in older Americans: the Third National Health and Nutrition Examination Survey (NHANES III). BMC Public Health 5:41-49, 2005
20. Petersen KF, Shulman GI: Etiology of insulin resistance. Am J Med 119:10S-16S, 2006
21. Singh MA: Exercise to prevent and treat functional disability. Clin Geriatr Med 18:431-462, 2002
22. Isidori AM, Strollo F, More M, Caprio M, Aversa A, Moretti C, Frajese G, Riondino G, Fabbri A: Leptin and aging: correlation with endocrine changes in male and female healthy adult populations of different body weights. J Clin Endocrinol Metab 85:1954-1962, 2000
23. Meneilly GS, Ryan AS, Veldhuis JD, Elahi D: Increased disorderliness of basal insulin release, attenuated insuin secretory burst mass, and reduced ultradian rhythm city of insulin secretion in older indivilduals. J Clin Endocrinol Metab 82:4088-4093, 1997
24. Meneilly GS, Veldhuis JD, Elahi D: Disruption of the pulsatile and entropic modes of insulin release during an unvarying glucose stimulus in elderly individuals. J Clin Endocrinol Metab 84:1938-1943, 1999
25. Meneilly GS, Elliott T: Metabolic alterations in middle-aged and elderly obese patients with type 2 diabetes. Diabetes Care 22:112-118, 1999
26. Toft-Nielsen MB, Damholt MB, Madsbad S, Hilsted LM, Hughes TE, Michelsen BK, Holst JJ: Determinants of the impaired secretion of glucagon-like peptide-1 in type 2 diabetic patients. J Clin Endocrinol Metab 86:3717-3723, 2001
27. Fehse F, Trautmann M, Holst JJ, Halseth AE, Nanayakkara N, Nielsen LL, Fineman MS, Kim DD, Nauck MA: Exenatide augments first- and second-phase insulin secretion in response to intravenous glucose in subjects with type 2 diabetes. J Clin Endocrinol Metab 90:5991-5997, 2005
28. Meneilly GS, Greig N, Tildesley H, Habener JF, Egan JM, Elahi D: Effects of 3 months of continuous subcutaneous administration of glucagon-like peptide 1 in elderly patients with type 2 diabetes. Diabetes Care 26:2835-2841, 2003
29. Farilla L, Bulotta A, Hirshberg B, Li Calzi S, Khoury N, Noushmehr H, Bertolotto C, Di Mario U, Harlan DM, Perfetti R: Glucagon-like peptide 1 inhibits cell apoptosis and improves glucose responsiveness of freshly isolated human islets. Endocrinology 144:5149-5158, 2003
30. Vaag A, Henriksen JE, Madsbad S, Holm N, Beck-Nielsen H: Insulin secretion, insulin action, and hepatic glucose production in identical twins discordant for non-insulin-dependent diabetes mellitus. J Clin Invest 95:690-698, 1995
31. Podolsky S: Diabetic complications: the diabetic foot. In Diabetes Mellitus in the Elderly. Gambert SR, Ed. New York, Raven Press, 1990, p. 87-103
32. Ward JD: The cost of diabetic foot problems. Pharmacoeconomics 8 (Suppl. 1):55-57, 1995
33. Borch-Johnsen K: The economics of screening for microalbuminuria in patients with insulin-dependent diabetes mellitus. Pharmacoeconomics 5:357-360, 1994
34. Varas-Lorenzo C, Rueda de Castro AM, Maguire A, Miret M, Blance C: Cardiovascular co-morbidigy in the U.S. elderly population with renal and glucose metabolism impairment: the Third National Health and Nutrition Examination Survey. Pharmacoepidemiol Drug Saf 11:S53-S57, 2002
35. Narins BE, Narins RG: Clinical features and health-care costs of diabetic nephropathy. Diabetes Care 11:833-839, 1988
36. Jacobs J, Sena M, Fox N: The cost of hospitalization for the late complications of diabetes in the United States. Diabet Med 8 (Symposium):S23S29, 1991
37. Wolf AM, Colditz GA: The cost of obesity: the U.S. perspective. Pharmacoeconomics 5 (Suppl. 1):34-37, 1994
38. Collings, RW, Anderson, JW: Medication cost savings associated with weight loss for obese non-insulin dependent diabetic men and women. Prevent Med 24:369-374, 1995
39. MacLeod KM, Tooke JE: Direct and indirect costs of cardiovascular and cerebrovascular complications of type II diabetes. Pharmacoeconomics 8 (Suppl. 1):46-51, 1995
40. American Diabetes Association: Economic consequences of diabetes mellitus in the U.S. in 1997. Diabetes Care 21:296-309, 1998
41. Weinberger M, Ault KA, Vinicor F: Prospective reimbursement and diabetes mellitus: impact upon glycemic control and utilization of health services. Med Care 26:77-83, 1988
42. Huse D, Oster G, Kilen A, Lacey M, Colditz G: The economic costs of non-insulin-dependent diabetes mellitus. JAMA 262:2708-2713, 1989
43. Bransome ED: Financing the care of diabetes mellitus in the U.S.: background, problems, and challenges. Diabetes Care 15 (Suppl. 1):1-5, 1992
44. Finder SF, Smith MD, McGhan WF: Digging out savings in diabetes care: costing out care. Bus Health 12:69-70, 72, 1996
45. Weinberger M, Cowper PA, Kirkman MS, Vinicor F: Economic impact of diabetes mellitus in the rlderly. Clin Geriatr Med 6:959-970, 1990
46. Rubin RJ, Altman WM, Mendelson DN: Health care expenditures for people with diabetes mellitus. J Clin Endocrinol Metab 78:809A-809F, 1994
47. Ray NF, Thamer M, Taylor T, Fehrenback SN, Ratner R: Hospitalization and expenditures for the treatment of general medical conditions among the U.S. diabetic population in 1991. J Clin Endocrinol Metab 81:3671-3679, 1996
48. Caruthers C: Tallying the cost of diabetes. Bus Health 14:SR8-SR13, 1996
49. Damsgaard EM: Why do elderly diabetics burden the health care system more than non-diabetics? Danish Med Bull 36:89-92, 1989
50. The DCCT Research Group: Resource utilization and costs of care in the Diabetes Control and Complications Trial. Diabetes Care 18:1468-1478, 1995
51. Conklin MS: Hospitals adopt intensive programs for diabetic patients to avoid high inpatient costs. Health Care Strateg Manage 12:11-13, 1994
52. Zimmet P: Diabetes epidemiology as a trigger to diabetes research. Diabetologia 42:499-518, 1999
53. Saadine JB, Cadwell B, Gregg EW, Engelgau MM, Vinicor R, Imperatore G, Narayan KM: Improvements in diabetes process of care and intermediate outcomes: United States, 1988-2002. Ann Intern Med 144:465-474, 2006
54. Thornley-Brown D, Wang X, Wright JT, Randall OS, Miller ER, Lash JP, Gassman J, Contreras G, Appel LJ, Agodoa LY, Check D: Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease. Arch Intern Med 166:799-805, 2006